Pediatric Infectious Disease

Register      Login

VOLUME 6 , ISSUE 1 ( January-March, 2024 ) > List of Articles


BioFire FilmArray Blood Culture Identification (BCID) Panel and Clinical Usefulness: A Systematic Review

Niti Gor, Devesh Joshi

Keywords : BioFire FilmArray, Blood culture identification panel, Clinical usefulness

Citation Information : Gor N, Joshi D. BioFire FilmArray Blood Culture Identification (BCID) Panel and Clinical Usefulness: A Systematic Review. Pediatr Inf Dis 2024; 6 (1):24-28.

DOI: 10.5005/jp-journals-10081-1419

License: CC BY-NC 4.0

Published Online: 16-03-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Introduction: In the critical care of septic patients, timely and accurate diagnosis is paramount. Molecular diagnostic studies that offer rapid and precise results are lacking. The BioFire blood culture identification (BCID) panel, a multiplex polymerase chain reaction (PCR) technique, enables earlier species identification, potentially influencing clinical decision-making. Materials and methods: This systematic review follows Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines, utilizing online databases such as PubMed and Google Scholar to assess the clinical utility of the BioFire BCID panel. A total of 654 articles were initially identified, narrowed down to 20 relevant articles after eliminating duplicates and less pertinent ones. A total of 11 articles were meticulously reviewed and analyzed. Results and discussion: BioFire demonstrated a remarkable ability to identify organisms within 9.5 hours, significantly faster than conventional methods taking around 16 hours. In approximately one-third to one-fourth of cases, the BCID panel contributed to earlier decision-making. The available evidence suggests that the BCID panel substantially reduces the time needed for optimal antibiotic administration and enhances the accuracy of empirical antibiotic selection. Despite its cost, the statistical utilization of the BCID panel can render it a cost-effective investigation. However, there is a risk of missing organisms not covered by the panel, emphasizing the need for increased awareness among physicians regarding the panel's limitations. Conclusion: In conclusion, the judicious use of the BCID panel, coupled with background knowledge, facilitates early decision-making in antibiotic selection. This tool proves valuable for antibiotic stewardship, aiding in the cessation of unnecessary antibiotic use. Increased physician awareness and proper utilization are crucial for maximizing the potential benefits of the BioFire BCID panel.

PDF Share
  1. Caliendo AM, Gilbert DN, Ginocchio CC, et al. Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis 2013;57 Suppl 3(Suppl 3):S139–S170. DOI: 10.1093/cid/cit578
  2. Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017;43(3):304–377. DOI: 10.1007/s00134-017-4683-6
  3. Afshari A, Schrenzel J, Ieven M, et al. Bench-to-bedside review: Rapid molecular diagnostics for bloodstream infection–a new frontier? Crit Care 2012;16(3):222. DOI: 10.1186/cc11202
  4. Riedel S, Carroll KC. Laboratory detection of sepsis: biomarkers and molecular approaches. Clin Lab Med 2013;33(3):413–437. DOI: 10.1016/j.cll.2013.03.006
  5. Lyle N, Boyd J. The potential for PCR based testing to improve diagnosis and treatment of sepsis. Curr Infect Dis Rep 2013;15(5):372–379. DOI: 10.1007/s11908-013-0350-4
  6. Westh H, Lisby G, Breysse F, et al. Multiplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis. Clin Microbiol Infect 2009;15(6):544–551. DOI: 10.1111/j.1469-0691.2009.02736.x
  7. Cantón R, Coque TM. The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 2006;9(5):466–475. DOI: 10.1016/j.mib.2006.08.011
  8. Mizusawa M. Updates on rapid diagnostic tests in infectious diseases. Mo Med 2020;117(4):328. PMID: 32848269.
  9. BioMérieux Diagnostics. BioFire FilmArray Blood Culture Identification (BCID) panel. Instruction booklet. RFIT-ASY-0126 RFIT-ASY-0127. Available from: (Accessed 17 Nov 2020).
  10. Leber AL. Clinical microbiology procedures handbook; 4th edition. Hoboken, NJ; John Wiley & Sons. 2016.
  11. Bamford C, Goodway J, Hoffmann R. Rapid identification and susceptibility testing of Gram-negative bacilli from blood cultures using the Vitek® 2 system. South Afr J Epidemiol Infect 2010;25(3):28–31. DOI: 10.1080/10158782.2010.11441396
  12. CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 30th edition. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute. 2020.
  13. Sparks R, Balgahom R, Janto C, et al. Evaluation of the BioFire blood culture identification 2 panel and impact on patient management and antimicrobial stewardship. Pathology 2021;53(7):889–895. DOI: 10.1016/j.pathol.2021.02.016
  14. Rule R, Paruk F, Becker P, et al. Clinical utility of the BioFire FilmArray Blood Culture Identification panel in the adjustment of empiric antimicrobial therapy in the critically ill septic patient. PLoS One 2021;16(7):e0254389. DOI: 10.1371/journal.pone.0254389
  15. Verroken A, Despas N, Rodriguez-Villalobos H, et al. The impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: a pre-post intervention study. PLoS One 2019;14(9):e0223122. DOI: 10.1371/journal.pone.0223122
  16. Caunedo-Jiménez M, Fernández-Colomer B, Fernández-Suárez J, et al. Clinical utility of the FilmArray(®) blood culture identification (BCID) panel for the diagnosis of neonatal sepsis. Microorganisms 2023;11(3). DOI: 10.3390/microorganisms11030732
  17. Tseng AS, Kasule SN, Rice F, et al. Is it actionable? An evaluation of the rapid pcr-based blood culture identification panel on the management of gram-positive and gram-negative blood stream infections. Open Forum Infect Dis 2018;5(12):ofy308. DOI: 10.1093/ofid/ofy308
  18. Bookstaver PB, Nimmich EB, Smith TJ 3rd, et al. Cumulative effect of an antimicrobial stewardship and rapid diagnostic testing bundle on early streamlining of antimicrobial therapy in gram-negative bloodstream infections. Antimicrob Agents Chemother 2017;61(9). DOI: 10.1128/AAC.00189-17
  19. MacVane SH, Nolte FS. Benefits of adding a rapid pcr-based blood culture identification panel to an established antimicrobial stewardship program. J Clin Microbiol 2016;54(10):2455–2463. DOI: 10.1128/JCM.00996-16
  20. Garner CD, Brazelton de Cardenas J, Suganda S, et al. Accuracy of broad-panel pcr-based bacterial identification for blood cultures in a pediatric oncology population. Microbiol Spectr 2021;9(1):e0022121. DOI: 10.1128/Spectrum.00221-21
  21. Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf 2014;5(6):229–241. DOI: 10.1177/2042098614554919
  22. Tamma PD, Avdic E, Li DX, et al. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med 2017;177(9):1308–1315. DOI: 10.1001/jamainternmed.2017.1938
  23. Britt NS, Khader K, He T, et al. Examining the clinical impact of rapid multiplex polymerase chain reaction-based diagnostic testing for bloodstream infections in a national cohort of the Veterans Health Administration. Pharmacotherapy 2023;43(1):24–34. DOI: 10.1002/phar.2747
  24. Chiasson JM, Smith WJ, Jodlowski TZ, et al. Impact of a rapid blood culture diagnostic panel on time to optimal antimicrobial therapy at a veterans affairs medical center. J Pharm Pract 2022;35(5):722–729. DOI: 10.1177/08971900211000686
  25. Kanda N, Hashimoto H, Suzuki T, et al. Performance of the new FilmArray blood culture identification 2 panel and its potential impact on clinical use in patients with Gram-negative bacteremia. J Infect Chemother 2022;28(7):1037–1040. DOI: 10.1016/j.jiac.2022.04.008
  26. El Sherif HM, Elsayed M, El-Ansary MR, et al. BioFire FilmArray BCID2 versus VITEK-2 system in determining microbial etiology and antibiotic-resistant genes of pathogens recovered from central line-associated bloodstream infections. Biology (Basel) 2022;11(11). DOI: 10.3390/biology11111573
  27. Mushtaq A, Chasan R, Nowak MD, et al. Correlation between identification of β-lactamase resistance genes and antimicrobial susceptibility profiles in gram-negative bacteria: a laboratory data analysis. Microbiol Spectr 2022;10(2):e0148521. DOI: 10.1128/spectrum.01485-21
  28. Donner LM, Campbell WS, Lyden E, et al. Assessment of rapid-blood-culture-identification result interpretation and antibiotic prescribing practices. J Clin Microbiol 2017;55(5):1496–1507. DOI: 10.1128/JCM.02395-16
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.